Plectin in skin fragility disorders
Abstract: Plectin is a multi-faceted, 500 kDa-large protein, which due to its expression in different isoforms and distinct organs acts diversely as a cytoskeletal crosslinker and signaling scaffold. It functions as a mediator of keratinocyte mechanical stability in the skin, primarily through linking intermediate filaments to hemidesmosomes. Skin fragility may occur through the presence of mutations in the gene encoding for plectin, PLEC, or through the presence of autoantibodies against the molecule. Below, we review the cutaneous manifestations of plectinopathies as well as their systemic involvement in specific disease subtypes. We summarize the known roles of plectin in keratinocytes and fibroblasts and provide an outlook on future perspectives for plectin-associated skin disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Cells. - 10, 10 (2021) , 2738, ISSN: 2073-4409
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
- DOI
-
10.3390/cells10102738
- URN
-
urn:nbn:de:bsz:25-freidok-2223411
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kiritsi, Dimitra
- Tsakiris, Leonidas
- Schauer, Franziska
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Treatment of Epidermolysis bullosa acquisita with dupilumab
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus: letter to the editor
Transition from Bullous Pemphigoid to Pemphigus Foliaceus: intermolecular epitope spreading thirteen years after initial diagnosis
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study
Polymorphisms in the mitochondrial genome are associated with bullous pemphigoid in germans
Targeting epidermal lipids for treatment of Mendelian disorders of cornification
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility
Radiation-associated pemphigus vulgaris in a patient with preceding malignancy: treatment with rituximab as a valuable option
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Treatment of Epidermolysis bullosa acquisita with dupilumab
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus: letter to the editor
Transition from Bullous Pemphigoid to Pemphigus Foliaceus: intermolecular epitope spreading thirteen years after initial diagnosis
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study
Polymorphisms in the mitochondrial genome are associated with bullous pemphigoid in germans
Targeting epidermal lipids for treatment of Mendelian disorders of cornification
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility
Radiation-associated pemphigus vulgaris in a patient with preceding malignancy: treatment with rituximab as a valuable option
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Treatment of Epidermolysis bullosa acquisita with dupilumab
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus: letter to the editor
Transition from Bullous Pemphigoid to Pemphigus Foliaceus: intermolecular epitope spreading thirteen years after initial diagnosis
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study
Polymorphisms in the mitochondrial genome are associated with bullous pemphigoid in germans
Targeting epidermal lipids for treatment of Mendelian disorders of cornification
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility